Joel Krikston

Joel Krikston is Managing Director Venture Investments and Head of Strategic Innovation Alliances. Joel is focused on identifying new investment opportunities with a focus on Oncology, Vaccines and Infectious Disease. Mr. Krikston has over 20 years of experience in healthcare innovation. Prior to joining Merck GHI in 2013, he was an Investment Principal at Johnson & Johnson Development Corporation. Joel also spent over eight years as an investment banker, covering an array of healthcare clients and included experience at BNP Paribas, JPMorgan and ABN Amro. Joel has an MBA from the Stern School of Business at NYU and completed his Bachelor’s degree in Finance and International Business at Fairfield University.

Education

• MBA NYU Stern School of Business (1997 — 1999)
• MIT Sloan Executive Education (2019 — 2019)
• Certificate Harvard T.H. Chan School of Public Health (2018 — 2018)
• Merck Emerging Leaders Program Harvard Business School
• Leadership Development Program Eckerd College
• BS Fairfield University (1988 — 1992)
• General Studies Mount Lebanon High School (1984 — 1988)
• Certificate Harvard T.H. Chan School of Public Health (2021 — 2021)

Companies

• Investor Unite Us (2021)
• Board Observer RxVantage (2020)
• Board Director Infectious Disease Connect (2020)
• Venture Mentor NYU Stern School of Business (2020)
• Board Observer GNS Healthcare (2019)
• Head of Strategic Innovation Alliances Merck Global Health Innovation Fund (2019)
• Venture Mentor The Cedars-Sinai Accelerator (2019)
• Guest Lecturer Princeton University (2018)
• Board Director Arcadia Healthcare Solutions (2016)